Close

Analyst Ratings for Turning Point Therapeutics Inc. (TPTX)

TPTX Rating Summary

TPTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TPTX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $66.67 (-12.3%) * Over Last 12-Mos
Rating Score: 3.6 / 10   Percentile Rank: 32%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/13/2022 Guggenheim Michael Schmidt Downgrade Neutral
(Buy)
76.00
(N/A)
74.47
(76.01)
2.07% Details
6/13/2022 SVB Leerink Andrew S. Berens Downgrade Market Perform
(Outperform)
76.00
(101.00)
74.47
(76.01)
2.07% Details
Like TPTX Ratings? Also take a look at BMY, ZLAB, SYNH, MWA

TPTX Ratings News